News
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
On Thursday, Reuters reported weak U.S. prescription data is contributing to investor concerns that Novo Nordisk is no longer ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
A decade after he was deep in film school debt, Ryan Coogler reportedly inked a deal with Warner Bros. that’ll give him the ...
(Reuters) -A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular ...
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...
Suspicious Ozempic products should be reported to Novo Nordisk or directly to the FDA. In addition, any adverse effects from ...
The surprising role lizard venom played in inventing Ozempic — as FDA warns about fakes being sold
Lizard venom has played a crucial part in helping humans take a bite out of diabetes and obesity. The Gila monster is a large, magnificent and venomous desert-dwelling reptile found throughout the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results